MARATTO

article · Mansoura Journal of Biology

Zinc-doped borate bioactive glasses: antibacterial efficacy and environmental application

2024Open accessMansoura University

Abstract

Reusing of the treated sewage wastewater is addressed as a significant alternative water source in the new water management strategies of Middle Eastern countries and other countries facing water resource shortages. By using the traditional melt-quenching procedure, borate bioactive glasses (BBAGs) doped with varying amounts of zinc oxide (ZnO) (ZnXs) were created. The used composition was (75-X) B2O3, 10 Na2O, 5 P2O5, 10 Li2O and X ZnO (i.e., X = 0, 5, 10, 15, and 25 mol%). Several analytical methods for energy-dispersive X-ray (EDX) spectroscopy and Fourier transform infrared (FTIR) spectroscopy were used to characterise the prepared Zn5. The prepared ZnXs showed antibacterial effects against Staphylococcus aureus, Bacillus cereus, Methicillin-resistant Staphylococcus aureus (MRSA), and Escherichia coli strains. Also, the prepared Zn5 showed in vitro antibacterial activity in a wastewater sample from Mansoura wastewater treatment plant in Dakahlia, Egypt. Finally, the incorporation of Zinc (Zn5) enhanced the antibacterial effect of the prepared BBAGs sample on bacteria from a sewage wastewater sample. The research results discussed the possible environmental applies of Zn-doped borate bioactive glasses.

Research topics

  • Bone Tissue Engineering Materials
  • Dental Erosion and Treatment
  • Medical and Biological Ozone Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/mjb.2024.447268

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.